Cannabinoids and Dementia A Review of Clinical and Preclinical Data.docVIP

Pharmaceuticals 2010, 3, 2689-2708; doi:10.3390/ph3082689 OPEN ACCESS pharmaceuticals ISSN 1424-8247 /journal/pharmaceuticals Review Cannabinoids and Dementia: A Review of Clinical and Preclinical Data Sebastian Walther * and Michael Halpern University Hospital of Psychiatry, Bolligenstrasse 111, 3000 Bern 60, Switzerland; E-Mail: Michael.Halpern@gef.be.ch (M.H.) * Author to whom correspondence should be addressed; E-Mail: walther@puk.unibe.ch; Tel.: +41-31-930-9111; Fax: +41-31-930-9404. Received: 23 June 2010; in revised form: 5 August 2010 / Accepted: 16 August 2010 / Published: 17 Augu